Anticancer agent 352
Anticancer agent 352 is a heterobifunctional anticancer compound. Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A). Anticancer agent 352 can be used in breast cancer-related research.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3099599-58-0
- Formel: C51H54N10O3S
- Molecular Weight:887.10
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
|
ERα |
Anticancer agent 352 (III-224) exhibits moderate antiproliferative activity against MCF7 cells (GI50 = 0.05-0.5 μM)[1].
Anticancer agent 352 exhibits only weak antiproliferative activity against both ERα-overexpressing and non-overexpressing T-Rex 293 cells induced by Doxorubicin (HY-15142A) (GI50 > 2.5 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS. Nr. 3099599-58-0
-
Molecular Weight 887.10
-
Formel C51H54N10O3S
-
SMILES
CC1=C(C)SC2=C1C(C3=CC=C(N4CCC(O)(CC4)CN5CCN(C6=CC=C([C@H]7C8=CC=C(O)C=C8CC[C@H]7C9=CC=CC=C9)N=N6)CC5)C=C3)=N[C@H](CC%10=NC=CO%10)C%11=NN=C(C)N2%11
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)